Inventor · disambiguated record
Zhe Nie
Also filed as: NIE ZHE
48 granted patents·14 pending applications·141 citations·filing 2007–2025
98Inventor score
Files withCELGENE QUANTICEL RES INC28QUANTICEL PHARMACEUTICALS INC10ANNAPURNA BIO INC4TAKEDA PHARMACEUTICAL3TAKEDA PHARMACEUTICALS CO3
Top patents by PatentIndex Score
62 records- 0197US9447045B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·20 cites·16 claims
- 0296US8987461B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Mar 24, 2015·13 cites·21 claims
- 0396US8952151B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Feb 10, 2015·21 cites·18 claims
- 0493US9085534B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jul 21, 2015·8 cites·34 claims
- 0592US9107916B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 18, 2015·4 cites·38 claims
- 0692US8440689B2Fused heteroaromatic pyrrolidinonesARIKAWA YASUYOSHI·Filed 2010·Granted May 14, 2013·23 cites·28 claims
- 0791US9133166B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2014·Granted Sep 15, 2015·10 cites·17 claims
- 0888US11214542B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 4, 2022·1 cites·17 claims
- 0987US2023286917A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 1086US10807956B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 20, 2020·1 cites·18 claims
- 1186US9676770B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jun 13, 2017·5 cites·15 claims
- 1285US10870634B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 22, 2020·1 cites·11 claims
- 1385US9725441B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 8, 2017·2 cites·20 claims
- 1483US10654830B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·1 cites·5 claims
- 1583US10597365B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Mar 24, 2020·1 cites·14 claims
- 1683US8318727B2Polo-like kinase inhibitorsCAO SHELDON X·Filed 2010·Granted Nov 27, 2012·13 cites·13 claims
- 1783US2023295171A1Fused heteroaromatic pyrrolidinonesCALITHERA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1882US11471455B2Compounds and compositions for treating conditions associated with APJ receptor activityANNAPURNA BIO INC·Filed 2022·Granted Oct 18, 2022·1 cites·20 claims
- 1982US10179769B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 15, 2019·1 cites·14 claims
- 2082US9828343B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Nov 28, 2017·1 cites·12 claims
- 2180US9611221B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Apr 4, 2017·1 cites·27 claims
- 2279US9527829B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2014·Granted Dec 27, 2016·2 cites·6 claims
- 2378US9108970B2Fused heteroaromatic pyrrolidinonesTAKEDA PHARMACEUTICAL·Filed 2013·Granted Aug 18, 2015·2 cites·31 claims
- 2477US10150754B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Dec 11, 2018·1 cites·12 claims
- 2577US9458129B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Oct 4, 2016·1 cites·22 claims
- 2675US9896436B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Feb 20, 2018·1 cites·7 claims
- 2775US9181255B2Fused heteroaromatic pyrrolidinones as SYK inhibitorsARIKAWA YASUYOSHI·Filed 2010·Granted Nov 10, 2015·2 cites·28 claims
- 2873US11884648B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 30, 2024·0 cites·4 claims
- 2973US9902719B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2015·Granted Feb 27, 2018·1 cites·21 claims
- 3073US7517882B2Protein kinase inhibitorsPOLARIS GROUP·Filed 2007·Granted Apr 14, 2009·3 cites·14 claims
- 3172US11639333B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted May 2, 2023·0 cites·9 claims
- 3271US9604961B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2013·Granted Mar 28, 2017·0 cites·2 claims
- 3369US10626103B2Inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Apr 21, 2020·0 cites·17 claims
- 3469US10626104B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Apr 21, 2020·0 cites·17 claims
- 3569US9714230B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Jul 25, 2017·0 cites·47 claims
- 3668US10173996B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 8, 2019·0 cites·4 claims
- 3768US9908865B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Mar 6, 2018·0 cites·34 claims
- 3868US2022306634A1Fused heteroaromatic pyrrolidinonesCALITHERA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3968US2024336590A1Compounds and compositions for treating conditions associated with apj receptor activityANNAPURNA BIO INC·Filed 2023·Application pending·0 cites
- 4064US10273222B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Apr 30, 2019·0 cites·18 claims
- 4163US10100046B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Oct 16, 2018·0 cites·8 claims
- 4263US9963441B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted May 8, 2018·0 cites·15 claims
- 4363US2018141951A1Fused heteroaromatic pyrrolidinonesTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 4462US12486269B2Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activityACONCAGUA BIO INC·Filed 2025·Granted Dec 2, 2025·0 cites·26 claims
- 4562US11944622B2Compounds and compositions for treating conditions associated with APJ receptor activityANNAPURNA BIO INC·Filed 2022·Granted Apr 2, 2024·0 cites·26 claims
- 4662US10174003B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 8, 2019·0 cites·12 claims
- 4761US2024246969A1Heterocyclic derivatives as camkk2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4860US10071984B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Sep 11, 2018·0 cites·28 claims
- 4959US10414750B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2015·Granted Sep 17, 2019·0 cites·19 claims
- 5059US8202990B2Polo-like kinase inhibitorsMCBRIDE CHRISTOPHER·Filed 2008·Granted Jun 19, 2012·0 cites·1 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhe Nie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →